{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:17:54Z","timestamp":1791152274931,"version":"4.1.0"},"reference-count":55,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2015,5,25]]},"published-print":{"date-parts":[[2016,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Caveats in the understanding of ribavirin (RBV) mechanisms of action has somehow prevented the development of better analogues able to further improve its therapeutic contribution in interferon (IFN)-based and direct antiviral agent-based regimens for chronic HCV or other indications. Here, we describe a new mechanism by which RBV modulates IFN-stimulated genes (ISGs) and contributes to restore hepatic immune responsiveness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>RBV effect on ISG expression was monitored in vitro and in vivo, that is, in non-transformed hepatocytes and in the liver of RBV mono-treated patients, respectively. Modulation of histone modifications and recruitment of histone-modifying enzymes at target promoters was analysed by chromatin immunoprecipitation in RBV-treated primary human hepatocytes and in patients\u2019 liver biopsies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>RBV decreases the mRNA levels of several abnormally preactivated ISGs in patients with HCV, who are non-responders to IFN therapy. RBV increases G9a histone methyltransferase recruitment and histone-H3 lysine-9 dimethylation\/trimethylation at selected ISG promoters in vitro and in vivo. G9a pharmacological blockade abolishes RBV-induced ISG downregulation and severely impairs RBV ability to potentiate IFN antiviral action and induction of ISGs following HCV infection of primary human hepatocytes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>RBV-induced epigenetic changes, leading to decreased ISG expression, restore an IFN-responsive hepatic environment in patients with HCV, which may also prove useful in IFN-free regimens.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2014-309011","type":"journal-article","created":{"date-parts":[[2015,6,16]],"date-time":"2015-06-16T23:00:54Z","timestamp":1434495654000},"page":"672-682","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":20,"title":["Ribavirin restores IFN\u03b1 responsiveness in HCV-infected livers by epigenetic remodelling at interferon stimulated genes"],"prefix":"10.1136","volume":"65","author":[{"given":"Barbara","family":"Testoni","sequence":"first","affiliation":[{"name":"INSERM U1052, Cancer Research Center of Lyon (CRCL), Lyon, France"},{"name":"University of Lyon, UCBL, UMR_S1052, Lyon, France"},{"name":"Hospices Civils de Lyon (HCL), Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Durantel","sequence":"additional","affiliation":[{"name":"INSERM U1052, Cancer Research Center of Lyon (CRCL), Lyon, France"},{"name":"University of Lyon, UCBL, UMR_S1052, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Leboss\u00e9","sequence":"additional","affiliation":[{"name":"INSERM U1052, Cancer Research Center of Lyon (CRCL), Lyon, France"},{"name":"University of Lyon, UCBL, UMR_S1052, Lyon, France"},{"name":"Hospices Civils de Lyon (HCL), Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Fresquet","sequence":"additional","affiliation":[{"name":"INSERM U1052, Cancer Research Center of Lyon (CRCL), Lyon, France"},{"name":"University of Lyon, UCBL, UMR_S1052, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Helle","sequence":"additional","affiliation":[{"name":"EA4294, Laboratoire de Virologie, Centre Hospitalier Universitaire et Universit\u00e9 de Picardie Jules Verne, Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Negro","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology and of Clinical Pathology, University Hospitals, Geneva 4, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Francesca","family":"Donato","sequence":"additional","affiliation":[{"name":"IRCSS Foundation Ca\u2019 Granda, Maggiore Hospital Policlinico and University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Levrero","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (DMISM) and the IIT-CNLS, Sapienza University of Rome, Rome, Italy"},{"name":"EAL INSERM U785, Villejuif, France"},{"name":"EAL INSERM U785, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Zoulim","sequence":"additional","affiliation":[{"name":"INSERM U1052, Cancer Research Center of Lyon (CRCL), Lyon, France"},{"name":"University of Lyon, UCBL, UMR_S1052, Lyon, France"},{"name":"Hospices Civils de Lyon (HCL), Lyon, France"},{"name":"Institut Universitaire de France (IUF), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2015,6,16]]},"reference":[{"key":"2025121303335658000_65.4.672.1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3851\/IMP2125","article-title":"The application and mechanism of action of ribavirin in therapy of hepatitis C","volume":"23","author":"Thomas","year":"2013","journal-title":"Antivir Chem Chemother"},{"key":"2025121303335658000_65.4.672.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2011.10.030"},{"key":"2025121303335658000_65.4.672.3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.12.002"},{"key":"2025121303335658000_65.4.672.4","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50217"},{"key":"2025121303335658000_65.4.672.5","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02778-12"},{"key":"2025121303335658000_65.4.672.6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.2001.00265.x"},{"key":"2025121303335658000_65.4.672.7","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.03.035"},{"key":"2025121303335658000_65.4.672.8","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.24035"},{"key":"2025121303335658000_65.4.672.9","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00382-07"},{"key":"2025121303335658000_65.4.672.10","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-12-199512150-00001"},{"key":"2025121303335658000_65.4.672.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(96)80225-X"},{"key":"2025121303335658000_65.4.672.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.1996.tb00050.x"},{"key":"2025121303335658000_65.4.672.13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.1998.00099.x"},{"key":"2025121303335658000_65.4.672.14","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302144"},{"key":"2025121303335658000_65.4.672.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1208953"},{"key":"2025121303335658000_65.4.672.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1315722"},{"key":"2025121303335658000_65.4.672.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402869"},{"key":"2025121303335658000_65.4.672.18","first-page":"297A","article-title":"High efficacy of treatment with Sofosbuvir+ GS-5816+\/-Ribavirin for 12 weeks in treatment experienced patients with genotype 1 or 3 HCV Infection","volume":"60","author":"Pianko","year":"2014","journal-title":"Hepatology"},{"key":"2025121303335658000_65.4.672.19","first-page":"320A","article-title":"Ledipasvir\/sofosbuvir with ribavirin for the treatment of HCV in patients with decompensated cirrhosis: preliminary results of a prospective, multicenter study","volume":"60","author":"Flamm","year":"2014","journal-title":"Hepatology"},{"key":"2025121303335658000_65.4.672.20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21853"},{"key":"2025121303335658000_65.4.672.21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027866"},{"key":"2025121303335658000_65.4.672.22","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23985"},{"key":"2025121303335658000_65.4.672.23","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis025"},{"key":"2025121303335658000_65.4.672.24","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-303852"},{"key":"2025121303335658000_65.4.672.25","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.128611"},{"key":"2025121303335658000_65.4.672.26","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.01.059"},{"key":"2025121303335658000_65.4.672.27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0707882105"},{"key":"2025121303335658000_65.4.672.28","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2008.75"},{"key":"2025121303335658000_65.4.672.29","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.231068"},{"key":"2025121303335658000_65.4.672.30","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2008.68"},{"key":"2025121303335658000_65.4.672.31","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.03.037"},{"key":"2025121303335658000_65.4.672.32","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.10.5933-5947.2003"},{"key":"2025121303335658000_65.4.672.33","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-60761-688-7_1"},{"key":"2025121303335658000_65.4.672.34","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26421"},{"key":"2025121303335658000_65.4.672.35","doi-asserted-by":"publisher","DOI":"10.1038\/nature05915"},{"key":"2025121303335658000_65.4.672.36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022281"},{"key":"2025121303335658000_65.4.672.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2007.01.017"},{"key":"2025121303335658000_65.4.672.38","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20112343"},{"key":"2025121303335658000_65.4.672.39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070809"},{"key":"2025121303335658000_65.4.672.40","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25897"},{"key":"2025121303335658000_65.4.672.41","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-60761-688-7_13"},{"key":"2025121303335658000_65.4.672.42","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.11.039"},{"key":"2025121303335658000_65.4.672.43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215246"},{"key":"2025121303335658000_65.4.672.44","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-38919-1_12"},{"key":"2025121303335658000_65.4.672.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2013.03.001"},{"key":"2025121303335658000_65.4.672.46","doi-asserted-by":"publisher","DOI":"10.1126\/science.177.4050.705"},{"key":"2025121303335658000_65.4.672.47","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2317"},{"key":"2025121303335658000_65.4.672.48","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12114"},{"issue":"(Suppl 1)","key":"2025121303335658000_65.4.672.49","first-page":"57","article-title":"Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C","volume":"19","author":"McHutchison","year":"1999","journal-title":"Semin Liver Dis"},{"key":"2025121303335658000_65.4.672.50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020047"},{"key":"2025121303335658000_65.4.672.51","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(14)60008-8"},{"key":"2025121303335658000_65.4.672.52","doi-asserted-by":"publisher","DOI":"10.1172\/JCI75938"},{"key":"2025121303335658000_65.4.672.53","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.111085598"},{"key":"2025121303335658000_65.4.672.54","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-3542(98)00029-1"},{"key":"2025121303335658000_65.4.672.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.10.019"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2014-309011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T11:34:01Z","timestamp":1765625641000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2014-309011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,16]]},"references-count":55,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,3,9]]},"published-print":{"date-parts":[[2016,4]]}},"alternative-id":["10.1136\/gutjnl-2014-309011"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2014-309011","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,16]]}}}